This mutation comprises a T to A transversion at nucleotide position 1319, resulting in replacement of valine by glutamic acid. (J:104190) Additional incidental mutations were detected in sequencing for the causative mutation, Nphp3pol, and may be present in stocks carrying this mutation.
Legend:
cx: complex: > 1 genome feature ot: other: hemizygous, indeterminate,... (F): Female
(M): Male
N: normal phenotype
(#): related diseases count